Safety of canadian drugs
Medical Letter on Drugs and Therapeutics 45(1171): 100
2003
ISSN/ISBN: 0025-732X PMID: 14657804 Document Number: 555986
Document emailed within 1 workday
Related Documents
Brotto, L.A.; Chou, A.Y.; Singh, T.; Woo, J.S.T. 2008: Reproductive health practices among Indian, Indo-Canadian, Canadian East Asian, and Euro-Canadian women: the role of acculturation Journal of Obstetrics and Gynaecology Canada: Jogc 30(3): 229-238D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Carruthers, J.; Carruthers, A. 2009: Two-center Canadian report on the safety and effectiveness of Evolence Breeze Journal of Drugs in Dermatology: Jdd 8(9): 830-834
Sato, T.; Kariya, K. 1996: Theoretical prediction of safety and efficacy of drugs--safety Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 108(3): 183-185
Shephard, R.J.; Lavallée, H.; Larivière, G.; Rajic, M.; Brisson, G.R.; Beaucage, C.; Jequier, J.C.; La Barre, R. 1974: Physical capacity of Canadian children: a comparison among French-Canadian, English-Canadian, and Eskimo children. I. Maximum oxygen consumption and cardiac output L'Union Medicale du Canada 103(10): 1767-1777
Fulda, T.K.; Dickens, P.F. 1979: Controlling the cost of drugs: the Canadian experience Health Care Financing Review 1(2): 55-64
Mailhot, J. 1993: Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study Clinical Therapeutics 15(6): 1060-1068
Montaner, J.S.; Rachlis, A.; Beaulieu, R.; Gill, J.; Schlech, W.; Phillips, P.; Auclair, C.; Boulerice, F.; Schindzielorz, A.; Smaldone, L. 1994: Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program Journal of Acquired Immune Deficiency Syndromes 7(9): 924-930
Moride, Y.; Ducruet, T.; Boivin, J-François.; Lavoie, Fédéric.; Rochon, S. 2005: Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines Canadian Journal of Clinical Pharmacology 12(2): E201-E211
Strachan, J.; Johansen, H.; Nair, C.; Nargundkar, M. 1990: Canadian suicide mortality rates: first-generation immigrants versus Canadian-born Health Reports 2(4): 327-341
Joffres, M.R.; Hamet, P.; Rabkin, S.W.; Gelskey, D.; Hogan, K.; Fodor, G. 1992: Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group Cmaj: Canadian Medical Association Journal 146(11): 1997-2005
MacLean, D.R.; Petrasovits, A.; Connelly, P.W.; Joffres, M.; O'Connor, B.; Little, J.A. 1999: Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group Canadian Journal of Cardiology 15(4): 434-444
Patterson, S.; Kaida, A.; Nguyen, P.; Dobrer, S.; Ogilvie, G.; Hogg, R.; Kerr, T.; Montaner, J.; Wood, E.; Milloy, M-J. 2016: Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis Cmaj Open 4(2): E169-E176
Mehta, D.; Saxena, A. 1990: Safety of use of antiarrhythmic drugs Indian Heart Journal 42(6): 445-450
Palaian, S.; Mishra, P.; Shankar, P.R.; Dubey, A.K.; Bista, D.; Almeida, R. 2006: Safety monitoring of drugs--where do we stand? Kathmandu University Medical Journal 4(1): 119-127
Robbins, N.; Barzel, U.S. 1988: Generic drugs--a question of safety New York State Journal of Medicine 88(8): 441-442
Verschuere, B.; Collin, A.; Landsmann, F.; Fabre, G.; Famose, F.; Gouy, D. 1990: Primates in studies on the safety of drugs Pathologie-Biologie 38(3): 221-224
Veronika, C.; Aron, F.; Peter, S. 2016: Safety risks of over-the-counter (OTC) drugs and their management Acta Pharmaceutica Hungarica 86(4): 151-159
Bowles, G.C. 1972: F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling Modern Hospital 118(3): 126
Barbanoj, M.J.; Lorenzo, J.L.; Clos, S.; García-Gea, C.; Jané, F. 2002: Proof of safety of drugs: focus on vigilance Methods and Findings in Experimental and Clinical Pharmacology 24 Suppl C: 51-64